We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$38.5B
AUM Growth
+$4.48B
(+13%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
2,364
New
149
Increased
1,180
Reduced
895
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$275M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$221M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$193M |
| 4 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$188M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$230M |
| 2 |
Spectrum Brands
SPB
|
+$81.6M |
| 3 |
Chevron
CVX
|
+$79.8M |
| 4 |
Pfizer
PFE
|
+$66.7M |
| 5 |
K
Kellanova
K
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.09% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Technology | 9.81% |
| 4 | Consumer Staples | 7.93% |
| 5 | Communication Services | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
First Trust Switzerland AlphaDEX Fund
FSZ
$36M
| $176M | 0.46% |
4,378,268
+3,636,600
| +490% | +$153M |
|
27
Booking.com
BKNG
$138B
| $174M | 0.45% |
3,787,200
+473,000
| +14% | +$22.6M |
|
|
FHK
28
DELISTED
First Trust Hong Kong AlphaDEX Fund
FHK
| $174M | 0.45% |
4,340,738
+3,605,440
| +490% | +$159M |
|
|
FNI
29
DELISTED
First Trust Chindia ETF
FNI
| $167M | 0.43% |
5,441,497
+4,519,720
| +490% | +$142M |
|
30
Salesforce
CRM
$134B
| $165M | 0.43% |
2,365,078
+236,420
| +11% | +$16.8M |
|
31
Novavax
NVAX
$1.23B
| $160M | 0.42% |
720,039
+14,137
| +2% | +$2.48M |
|
|
KRFT
32
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $157M | 0.41% |
1,840,511
+914,368
| +99% | +$78.7M |
|
|
YHOO
33
DELISTED
Yahoo Inc
YHOO
| $156M | 0.41% |
3,979,770
+561,713
| +16% | +$24.1M |
|
|
SGEN
34
DELISTED
Seagen Inc. Common Stock
SGEN
| $156M | 0.4% |
3,216,228
+151,899
| +5% | +$6.27M |
|
35
CVS Health
CVS
$137B
| $151M | 0.39% |
1,438,186
+70,547
| +5% | +$7.21M |
|
36
Bio-Techne
TECH
$11.2B
| $151M | 0.39% |
6,119,680
+1,987,772
| +48% | +$49.6M |
|
|
WWAV
37
DELISTED
The WhiteWave Foods Company
WWAV
| $150M | 0.39% |
3,064,728
+1,228,119
| +67% | +$57.5M |
|
38
Myriad Genetics
MYGN
$530M
| $147M | 0.38% |
4,321,509
+995,270
| +30% | +$33.8M |
|
|
EXAS
39
DELISTED
Exact Sciences
EXAS
| $145M | 0.38% |
4,864,564
+1,380,913
| +40% | +$34.7M |
|
|
ALXN
40
DELISTED
Alexion Pharmaceuticals
ALXN
| $144M | 0.37% |
796,271
-157,408
| -17% | -$27.2M |
|
41
Cigna
CI
$76.6B
| $142M | 0.37% |
874,421
+201,240
| +30% | +$27.8M |
|
42
Amgen
AMGN
$203B
| $141M | 0.37% |
918,493
-188,722
| -17% | -$30.2M |
|
43
Constellation Brands
STZ
$22.2B
| $138M | 0.36% |
1,185,901
-29,777
| -2% | -$3.52M |
|
|
AET
44
DELISTED
Aetna Inc
AET
| $135M | 0.35% |
1,059,311
+90,093
| +9% | +$10.3M |
|
45
Kroger
KR
$34.8B
| $134M | 0.35% |
3,707,968
-160,616
| -4% | -$5.84M |
|
|
WBA
46
DELISTED
Walgreens Boots Alliance
WBA
| $133M | 0.34% |
1,572,685
+25,902
| +2% | +$2.23M |
|
47
Tyson Foods
TSN
$20.2B
| $129M | 0.33% |
3,025,463
+441,614
| +17% | +$18.1M |
|
48
ExxonMobil
XOM
$651B
| $129M | 0.33% |
1,548,221
+1,053,894
| +213% | +$90.6M |
|
49
Apple
AAPL
$4.89T
| $128M | 0.33% |
4,080,684
+238,580
| +6% | +$7.63M |
|
|
CPHD
50
DELISTED
Cepheid Inc
CPHD
| $128M | 0.33% |
2,087,768
+346,425
| +20% | +$19.8M |
|
Similar funds
DAM
First Trust Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, First Trust Advisors held 2,364 positions worth $38.5B, up 13% from $34B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
First Trust Advisors deployed $4.55B of net new capital in Q2 2015, opening 149 new positions and adding to 1,180 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Chevron, an estimated $79.8M trimmed.
- First Trust Advisors's largest Q2 2015 buy was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q2 2015, an estimated $275M increase.
- First Trust Advisors's biggest Q2 2015 reduction was Chevron, cutting an estimated $79.8M.
- First Trust Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $230M.
- First Trust Advisors's ten largest holdings make up 14% of its $38.5B portfolio in Q2 2015.
- First Trust Advisors opened 149 new positions and closed 134 in Q2 2015.
- First Trust Advisors's portfolio value rose 13% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q2 2015, filed 4 Aug 2015.